loadpatents
name:-0.01685094833374
name:-0.019461870193481
name:-0.0023820400238037
Falkner; Falko-Guenter Patent Filings

Falkner; Falko-Guenter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Falkner; Falko-Guenter.The latest application filed is for "vaccine formulations and uses thereof".

Company Profile
0.18.8
  • Falkner; Falko-Guenter - Orth/Donau AT
  • Falkner; Falko-Guenter - Ortho/Donau AT
  • Falkner, Falko-Guenter - Orth Donau
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Production of viral vaccine
Grant 9,884,105 - Kistner , et al. February 6, 2
2018-02-06
Vaccine formulations and uses thereof
Grant 8,795,683 - Oberreither , et al. August 5, 2
2014-08-05
Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methods
Grant 8,753,648 - Falkner , et al. June 17, 2
2014-06-17
Vaccine Formulations and Uses Thereof
App 20120201847 - Oberreither; Manfred ;   et al.
2012-08-09
Vaccine formulations and uses thereof
Grant 7,998,488 - Oberreither , et al. August 16, 2
2011-08-16
Production of Viral Vaccine
App 20100189745 - Kistner; Otfried ;   et al.
2010-07-29
Vaccine Formulations And Uses Thereof
App 20100124557 - Oberreither; Manfred ;   et al.
2010-05-20
Factor IX/factor IXa activating antibodies and antibody derivatives
Grant 7,279,161 - Scheiflinger , et al. October 9, 2
2007-10-09
Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methods
App 20060093620 - Falkner; Falko-Guenter ;   et al.
2006-05-04
Factor IX/factor IXa activating antibodies and antibody derivatives
Grant 7,033,590 - Scheiflinger , et al. April 25, 2
2006-04-25
Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methods
Grant 7,025,970 - Falkner , et al. April 11, 2
2006-04-11
Factor IX/factor IXa activating antibodies and antibody derivatives
App 20050196397 - Scheiflinger, Friedrich ;   et al.
2005-09-08
Nucleic acids encoding factor X deletion mutants and analogues thereof
Grant 6,905,846 - Himmelspach , et al. June 14, 2
2005-06-14
Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methods
App 20030228330 - Falkner, Falko-Guenter ;   et al.
2003-12-11
Factor X deletion mutants and analogues thereof
App 20030138914 - Himmelspach, Michele ;   et al.
2003-07-24
Factor X deletion mutants and analogues thereof
Grant 6,562,598 - Himmelspach , et al. May 13, 2
2003-05-13
Targeted angiogenesis
App 20020019350 - Levine, Arnold J. ;   et al.
2002-02-14
Fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterologous sequence
Grant 6,210,929 - Schlokat , et al. April 3, 2
2001-04-03
Expression plasmid, a fusion protein, a transfected eukaryotic cell line, a method of producing foreign proteins, a foreign protein preparation as well as a pharmaceutical composition
Grant 6,114,146 - Herlitschka , et al. September 5, 2
2000-09-05
Method for isolation of highly pure von willebrand factor
Grant 5,880,265 - Fischer , et al. March 9, 1
1999-03-09
Method for isolation of highly pure von Willebrand Factor
Grant 5,877,152 - Fischer , et al. March 2, 1
1999-03-02
Method for isolation of highly pure von Willebrand Factor
Grant 5,854,403 - Fischer , et al. December 29, 1
1998-12-29
Method of quantitating nucleic acid
Grant 5,789,153 - Falkner , et al. August 4, 1
1998-08-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed